Healthcare · Vaccine antigens production
In 2026, Iran did not produce vaccine antigens on an industrial scale (0 million doses), ranking 72nd globally. The country relies entirely on imported substances for vaccine manufacturing, though local filling and finishing capacities are expanding. The Pasteur Institute of Iran and Hayat Daru are conducting R&D, but mass antigen production has not yet begun.
Data for 2026 · unit: million doses
Position
#72 / 197
Iran world ranking
Country position on the scale from last to first place for this indicator.
IR
#72
#197#1
Trend
Change over time
Change in indicator over the available period.
1
1950
0
1990
0
2000
0
2010
0
2020
0
2025
0
2026
Values — million doses
Comparison
Top countries by Vaccine antigens production
Where Iran stands in the world ranking.
1
CNChina
5 K
2
USUSA
500
3
BRBrazil
400
4
FRFrance
160
5
INIndia
100
5
RURussia
100
7
CACanada
60
8
AUAustralia
50
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Vaccine antigens production in Iran — how much?
Based on 2026 data — 0 million doses. This is rank #72 out of 197 countries.
What is Iran's rank by Vaccine antigens production?
Iran ranks #72 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Iran?
Over the available period the indicator changed from 1 to 0 million doses.